Natasha Catlin, PhD, DABT, is a Senior Principal Scientist in Nonclinical Drug Safety at Pfizer, where they have held various scientific positions since 2021. Prior to this, Natasha completed postdoctoral fellowships at the National Toxicology Program and Brown University from 2014 to 2017 and 2013 to 2014, respectively. They earned a PhD in Pathology and Laboratory Medicine from Brown University in 2014, with a dissertation focused on the apoptotic response of the rat testis to low dose co-exposures. Natasha also holds a Bachelor of Science in Biology from Salve Regina University, awarded in 2008.
This person is not in any teams
This person is not in any offices